A detailed history of Caption Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Caption Management, LLC holds 117,000 shares of IONS stock, worth $4.46 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
117,000
Previous 329,300 64.47%
Holding current value
$4.46 Million
Previous $15.7 Million 70.14%
% of portfolio
0.08%
Previous 0.26%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $5.34 Million - $6.92 Million
-133,400 Reduced 83.38%
26,600 $1.07 Million
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $5.83 Million - $7.63 Million
160,000 New
160,000 $7.63 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $476,836 - $585,040
14,200 Added 109.23%
27,200 $972,000
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $482,559 - $604,760
13,000 New
13,000 $491,000
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $358,560 - $444,480
-12,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $2.79 Million - $3.83 Million
-108,993 Reduced 90.08%
12,000 $366,000
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $838,030 - $1.01 Million
24,986 Added 26.03%
120,993 $4.06 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $1.76 Million - $2.4 Million
50,880 Added 112.75%
96,007 $3.83 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $3.62 Million - $4.81 Million
-79,873 Reduced 63.9%
45,127 $2.55 Million
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $1.58 Million - $2.09 Million
-33,276 Reduced 21.02%
125,000 $5.93 Million
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $7.42 Million - $9.66 Million
158,276 New
158,276 $9.33 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.